News & Views

Proactive IV Iron Therapy in Haemodialysis Patients: The PIVOTAL Trial

As highlighted by the recently published KDIGO Controversies Conference findings, questions remain regarding the benefits and safety of IV iron use in patients with chronic kidney disease (CKD). An ongoing study which hopes to provide many of the answers is the “groundbreaking” PIVOTAL Trial.[1] Led by Dr Iain Macdougall, Professor…

Read more

Date of publication:
May 19, 2016

News & Views

Highlights from the FIND-CKD Study

The FIND-CKD study results reported by Iain Macdougall and colleagues provide much needed information on the effects of IV iron therapy in non-dialysis-dependent chronic kidney disease patients.[1] 626 patients from 20 countries met the inclusion criteria, which included: CKD Stage 3-5ND Relatively stable eGFR decline No exposure to ESA therapy…

Read more

Date of publication:
May 19, 2016

News & Views

Practice Guidelines for Iron Deficiency and Anemia in CKD

Iron deficiency anemia is common in patients with chronic kidney disease (CKD). As kidney function declines, the incidence and prevalence of anemia increases, particularly in patients with more advanced CKD. Anemia occurs due to loss of functional kidney mass and can be worsened by gastrointestinal bleeding, hemodialysis, frequent blood sampling,…

Read more

Date of publication:
May 19, 2016

News & Views

Preview of ERA-EDTA 2016: Iron Deficiency & Anemia

The ERA-EDTA 2016 Congress starts this weekend in Vienna. To guide you through the Congress, the COMPACT RENAL team has highlighted key sessions and posters relating to iron deficiency and anemia. We will be distributing complimentary booklets at the congress, featuring our most popular articles and other resources, so please…

Read more

Date of publication:
May 18, 2016

Medical Education

Module 2: The Pathophysiology of Iron Deficiency

Iron deficiency/iron deficiency-anaemia (ID/IDA) is a common co-morbidity of chronic kidney disease (CKD)[1,2] and, if left untreated, can worsen the outcome of patients who already have compromised renal function.[3] We also now know that ID is not a single condition, but comprise multiple ID syndromes, with or without anaemia, which…

Read more

Date of publication:
October 9, 2015

Presentation Resources

ERA-EDTA 2015 Symposium: How to Treat in CKD – Choosing the Right Treatment for the Right Patient

Iron deficiency (ID) is prevalent in both patients with non-dialysis chronic kidney disease (ND-CKD) and haemodialysis chronic kidney disease (HD-CKD);(1,2) however, treatment options differ between the two patient groups. Either oral or intravenous (IV) iron agents can be used to treat ID in patients with ND-CKD,(3) whereas ID in patients…

Read more

Date of publication:
May 20, 2015

Expert Perspectives

Expert Panel Discussion: Oral vs. IV Iron Therapy

Iron therapy is an essential component of treating iron deficiency/iron deficiency-anaemia (ID/IDA) in patients with non-dialysis chronic kidney disease (ND-CKD); however, the best route of administration, intravenous (IV) or oral, remains an area of debate.(1,2) Meta-analysis of several studies is one approach to increase the power of detecting a statistically-…

Read more

Date of publication:
November 3, 2014

Login

You are about to leave Compact-Renal.com

Clicking the "Continue" link below will take you to an external website. Compact Renal is not responsible for the contents of any external website. Compact Renal is providing these links to you as a convenience, and the inclusion of any links does not imply endorsement of the linked site by Compact Renal.

Do you wish to continue?

Continue Cancel